Aadi Bioscience, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
AADI on Nasdaq
Industry
Pharmaceutical Preparations
Location
17383 Sunset Avenue, Suite A250, Pacific Palisades, CA

Insiders trading volume in the past year

Aadi Bioscience, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Neil Desai EXECUTIVE CHAIRMAN, Director $2M -$1.24M -38.3% Sep 3, 2024
Bryan Ball Exhibit 24 - Power of Attorney Chief Technical Operations Officer and SVP, Manufacturing Operations $223K Apr 23, 2024
David James Lennon CHIEF EXECUTIVE OFFICER, Director $113K Mar 1, 2024
Lorettta M. Itri Chief Medical Officer $52.3K Mar 1, 2024
Steven Prelack Director $50.5K Jun 30, 2021
Scott M. Giacobello Chief Financial Officer $47.1K Mar 1, 2024
Brendan Delaney President and Chief Executive Officer, Director $41.2K Mar 1, 2023
Cheryl Cohen Director $33.3K Jun 30, 2021
Pravin Dugel Director $25.9K Jun 30, 2021
Mohammad Hirmand Director Jun 12, 2024
Richard E. Maroun Director Jun 12, 2024
Lance E. Thibault Chief Financial Officer Aug 26, 2021
Caley Castelein Director Jun 12, 2024
Emma Reeve Director Jun 12, 2024
Anupam Dalal Director Jun 12, 2024
Behzad Aghazadeh Director, Other*, 10%+ Owner Jun 12, 2024
Karin M. Hehenberger Director Jun 12, 2024

Recent Insider Transactions by Companies or Individuals for Aadi Bioscience, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.